Term ends Apr 14, 2038 · High confidence
20-year base term ends Dec 2, 2036
Held by Pharaoh Neuro, Inc.
Filed Jan 14, 2020 as application 16/742,870 · Granted Feb 14, 2023
Base term plus 498 days of patent term adjustment (USPTO delay)
Today
2016
2038
Clock starts
Dec 2, 2016
Dec 2, 2016
Term ends
Apr 14, 2038
Apr 14, 2038
Granted
Feb 14, 2023
Feb 14, 2023
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
498
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,695,545, to Apr 14, 2038. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 498 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 2, 2016, when application 15/367,592, the earliest non-provisional in its chain, was filed (this one was filed Jan 14, 2020) | Dec 2, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +498 days, USPTO patent term adjustment record | Apr 14, 2038 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,695,545) | resolves to Apr 14, 2038, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 14, 2038 | High confidence |
This family
| US 10,695,545 | In force May 2038 | May 2038 |
| US 11,577,060 | this patent Apr 2038 | Apr 2038 |
| US 12,576,251 | In force Jul 2038 | Jul 2038 |
| Application 19/560,265 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 4, 2021 Reel 54795, frame 607 | Minnetronix Medical, Inc.; Minnetronix Neuro, Inc. | First Horizon Bank, As Administrative Agent | Security Interest |
| Mar 13, 2025 Reel 73460, frame 969 | First Horizon Bank | Texas Capital Bank, As Successor Agent | Assignment of Security Interest in Patent Collateral Recorded on Reel 054795 Frame 0607 and Supplemental Patent Security Agreement Recorded on Reel 056240 Frame 0147 |
| Jun 10, 2025 Reel 71588, frame 15 | Texas Capital Bank, As Administrative Agent | Minnetronix, Inc.; Minnetronix Neuro, Inc. (F/K/A Neurofluidics, Inc.) | Partial Release of Patent Security Agreement - Reel 054795 Frame 0607; and Reel 056240 Frame 0147 |
| Jun 10, 2025 reel/frame not recorded | Texas Capital Bank, As Administrative Agent | Minnetronix, Inc. | Partial Release of Patent Security Agreement - Reel 054795 Frame 0607; and Reel 056240 Frame 0147 |
| Jun 10, 2025 reel/frame not recorded | Texas Capital Bank, As Administrative Agent | Minnetronix Neuro, Inc. (F/K/A Neurofluidics, Inc.) | Partial Release of Patent Security Agreement - Reel 054795 Frame 0607; and Reel 056240 Frame 0147 |
| Jul 2, 2025 Reel 71588, frame 980 | Minnetronix, Inc. | Minnetronix Neuro, Inc. | Assignment of Assignor's Interest |
| Oct 1, 2025 Reel 73434, frame 838 | Texas Capital Bank, As Agent | Minnetronix Medical, Inc. | Release of Patent Security Agreement - Reel/Frame 054795/0607, Supplemental Patent Security Agreement - Real/Frame 056240/0147 and Assignment Id: 885388 |
| Oct 29, 2025 Reel 73429, frame 607 | Minnetronix Neuro, Inc. | Pharaoh Neuro, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2038
Term ends Apr 14, 2038. Maintenance fees still fall due before then
Note
The 498 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,695,545, ends no earlier than this term, so it caps nothing.
Citations
3
later US patents cite this one
That is top 25% of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.